NEOIMMUNE
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announced the completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initi... ated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products.
NEOIMMUNE
Industry:
Biotechnology Health Care Medical
Founded:
2019-12-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.neoimmune.cn
Total Employee:
11+
Status:
Active
Contact:
+86 0755-32960061
Total Funding:
30 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro Pound Sterling Japanese Yen
Current Employees Featured
Investors List
Spark Ventures
Spark Ventures investment in Seed Round - NeoImmune
Kindstar Global (Beijing) Medicine Technology
Kindstar Global (Beijing) Medicine Technology investment in Seed Round - NeoImmune
More informations about "NeoImmune"
泛因医学-Neoimmune
泛因医学IGHV突变检测产品：NEO-SHM2023年4月11日，泛因医学发布新产品：NEO-SHM，该产品基于泛因医学独立研发的多重PCR文库构建方法，通过二代测序（NGS）对Ig …See details»
NeoImmune泛因医学 - NeoImmune, NGS, Fanyin, fanyinyixue, …
In March 2021, NEO-MRD, the first domestic blood tumor MRD testing product independently developed by Pan Genetics, obtained the EU CE admission qualification. Our main purpose is …See details»
公司简介 - NeoImmune
依托免疫组学NGS技术，泛因医学为疾病发现、检测、监测等全过程提供产品解决方案，长期扎根于血液肿瘤领域，主要从事急性白血病、淋巴瘤等疾病的检测和监测。 作为国内优秀的免疫 …See details»
NeoImmune - Crunchbase Company Profile & Funding
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.See details»
NeoImmune Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for NeoImmune. Use the PitchBook Platform to explore the full profile.See details»
创始团队 - NeoImmune
公司的核心团队具有清华、中科大、南科大、华大等背景，具有多年的免疫组学经验以及项目研发经历，发表多篇论文并获得多项专利及软著。See details»
新闻中心 - neoimmune.cn
喜报！热烈祝贺泛因医学通过2023年深圳市专精特新中小企. 2024.01 “专精特新”一词最早来自于2011年7月25日，由时任工信部总工程师的朱宏任在《中国产业发展和产业政策报告(2011)》 …See details»
NeoImmune - Crunchbase
NeoImmune specializes in technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications. Novellus is a biotechnology company working …See details»
NeoImmune - Funding, Financials, Valuation & Investors
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.See details»
PIRD: Pan immune repertoire database - CNGBdb
Pan immune repertoire database (PIRD) collects raw and processed sequences of immunoglobulins (IGs) and T cell receptors (TCRs) of human and other vertebrate species …See details»
Company profile: NeoImmuneTech | pharmaphorum
Jan 29, 2014 · At NeoImmuneTech, a Biotech company founded in Maryland, US, in 2014, the answer to this question looks straightforward: “We believe in incremental progress”, says Dr Se Hwan Yang, president and...See details»
Shenzhen Neoimmune Co., Ltd announced the completion of tens …
On November 2021, 11, Shenzhen Neoimmune Co., Ltd, a clinical immunology company, announced the completion of tens of millions of RMB PreA financing. This round of investment …See details»
公司新闻 - neoimmune.com.cn
“专精特新”一词最早来自于2011年7月25日，由时任工信部总工程师的朱宏任在《中国产业发展和产业政策报告 (2011)》新闻发布会上首次提出。 中央层面上，2019年8月26日的中央财经委 …See details»
PIRD: Pan immune repertoire database - CNGBdb - db.cngb.org
Pan immune repertoire database (PIRD) collects raw and processed sequences of immunoglobulins (IGs) and T cell receptors (TCRs) of human and other vertebrate species …See details»
NeoImmuneTech - Crunchbase Company Profile & Funding
NeoImmuneTech is a biotech company developing T cell-centered novel immunotherapeutics. View contacts for NeoImmuneTech to access new leads and connect with decision-makers.See details»
PIRD: Pan immune repertoire database - CNGBdb - db.cngb.org
The PIRD database is temporarily offline due to technique issues. We apologize for any inconveniences. For other ways to view PIRD data, contact [email protected] please.See details»
公司简介 - neoimmune.cn
依托免疫组学NGS技术，泛因医学为疾病发现、检测、监测等全过程提供产品解决方案，长期扎根于血液肿瘤领域，主要从事急性白血病、淋巴瘤等疾病的检测和监测。 作为国内优秀的免疫 …See details»